SLL (SMALL LYMPHOCYTIC LYMPHOMA)

Clinical trials for SLL (SMALL LYMPHOCYTIC LYMPHOMA) explained in plain language.

Never miss a new study

Get alerted when new SLL (SMALL LYMPHOCYTIC LYMPHOMA) trials appear

Sign up with your email to follow new studies for SLL (SMALL LYMPHOCYTIC LYMPHOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 2

New hope for tough blood cancers: first patients test experimental drug

Disease control Recruiting now

This is the first study in people testing a new drug called ZE50-0134 for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to other treatments. The main goals are to find a safe dose and see how the body h…

Matched conditions: SLL (SMALL LYMPHOCYTIC LYMPHOMA)

Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

SLL (SMALL LYMPHOCYTIC LYMPHOMA)

Get alerted when new SLL (SMALL LYMPHOCYTIC LYMPHOMA) trials appear

New hope for tough blood cancers: first patients test experimental drug